Sundrug Co.,Ltd. (TYO:9989)

Market Cap	560.98B
Revenue (ttm)	801.81B
Net Income (ttm)	30.75B
Shares Out	116.97M
EPS (ttm)	262.90
PE Ratio	18.24
Forward PE	17.23
Dividend	131.00 (2.75%)
Ex-Dividend Date	Sep 29, 2025

Volume	336,600
Average Volume	262,110
Open	4,750.00
Previous Close	4,755.00
Day's Range	4,732.00 - 4,814.00
52-Week Range	3,439.00 - 4,883.00
Beta	0.22
RSI	71.79
Earnings Date	Aug 14, 2025

About G1 Therapeutics

Sundrug Co.,Ltd. operates and manages drug stores and dispensing pharmacies in Japan. The company operates through Drug Store Business and Discount Store Business segments. The Drug Store Business segment primarily sells pharmaceutical products, cosmetics, and daily necessities. The Discount Store Business segment offers food and household products. The company was founded in 1957 and is headquartered in Fuchu, Japan.

• Industry: Medical - Pharmaceuticals
• Sector: Healthcare
• Founded: 1957
• Employees: 7,145
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 9989

Financial Performance

In 2024, Sundrug's revenue was 801.81 billion, an increase of 6.66% compared to the previous year's 751.78 billion. Earnings were 30.75 billion, an increase of 5.58%.